Abstract
Purpose Recently, attention has been focused on the adverse drug reactions of topical timolol, especially with regard to respiratory function in the elderly. This study was designed to assess whether timolol causes an alteration in lung function in patients without pre-existing respiratory disease and who have not suffered the impact of long-term β2 blockade.
Methods A placebo-controlled randomised, double-masked, cross-over study was carried out on 20 ocular hypertensive patients with intraocular pressures over 21 mmHg, normal optic discs and full visual fields by Humphrey perimetry. Subjects received single-dose units of timolol maleate 0.5% drops or normal saline drops. Both were instilled in one eye or systemically (sublingually). The peak expiratory flow rate (PFR), forced expiratory volume (FEV), vital capacity (VC) and FEV/VC (%) ratio were all measured both before and after each type of drop and route of administration.
Results Two hours after instillation of timolol there was no change in PFR (p = 0.67) or VC (p = 0.40), but there was a fall in FEV (p = 0.038) and the FEV/VC (%) ratio (p = 0.041). The fall was greatest after topical administration.
Conclusions Our results show that in our group of patients there was a tendency towards mild bronchial obstruction after topical timolol, although this was not clinically significant.
Similar content being viewed by others
Article PDF
References
Diggory P, Heyworth P, Chau G, McKenzie S, Sharma A, Luke I . Improved lung function tests on changing from topical timolol: non-selective beta-blockade impairs lung function tests in elderly patients. Eye 1993;7:661–3.
Sadiq SA, Vernon SA . Sublingual timolol: an alternative to topical medication in glaucoma? Br J Ophthalmol 1996;80:532–5.
Graft DF, Fowles J, McCoy CE, Lager RA . Detection of βblocker use in people with asthma. Ann Allergy 1992;69:449–53.
Renwick DS, Connolly MJ . Prevalence and treatment of chronic airways obstruction in older adults. Age Aging 1994;23 (Suppl 2):6.
Spaeth G, Birbilis E . The effect of glaucoma and treatment of glaucoma on quality of life. In: Krieglstein E, editor. Glaucoma update, vol IV. Berlin: Springer-Verlag, 1991:2.6–7.
Beta-adrenoceptor blocking drugs. In: British national formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1995:70–2.
Pride NB . Lung function testing. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine, vol 2. New York: Oxford University Press, 1996:2666–75.
Vuori ML, Kaila T . Plasma kinetics and antagonist activity of topical ocular timolol in elderly patients. Graefes Arch Clin Exp Ophthalmol 1995;233:131–4.
Alvan G, Calissendorff B, Seideman P, Widmark K, Widmark G . Absorption of ocular timolol. Clin Pharmacokinet 1980;5:95–100.
Zimmerman TJ, Kooner KS, Kandarakis AS, et al. Improving therapeutic index of ocular drugs. Arch Ophthalmol 1984;102:551–3.
Olah TV, Gilbert JD, Barrish A . Determination of the β-adrenergic blocker timolol in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Pharm Biomed Anal 1993;11:157–63.
Author information
Authors and Affiliations
Additional information
Presented in part at the Glaucoma Society, London, November 1995, and at the Annual Congress of the Royal College of Ophthalmologists, Edinburgh, May 1996
Rights and permissions
About this article
Cite this article
Sadiq, S., Fielding, K. & Vernon, S. The effect of timolol drops on respiratory function. Eye 12, 386–389 (1998). https://doi.org/10.1038/eye.1998.91
Issue Date:
DOI: https://doi.org/10.1038/eye.1998.91